All Comments by Nikolaos K. Robakis

  1. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.
  2. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.
  3. C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP alpha and A beta by human cells and are degraded by proteasome.
  4. Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice.
  5. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion.
  6. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients.
  7. Carnosine, a protective, anti-ageing peptide?
  8. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity.
  9. Somatic mutation analysis of the APP and Presenilin 1 and 2 genes in Alzheimer's disease brains.
  10. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy.
  11. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.
  12. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.
  13. Laminin inhibits Abeta42 fibril formation in vitro.
  14. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease.
  15. Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules.